{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:03:26Z","timestamp":1788404606461,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1113007"],"award-info":[{"award-number":["OPP1113007"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Enteric fever can lead to prolonged hospital stays, clinical complications, and death. The Surveillance for Enteric Fever in Asia Project (SEAP), a prospective surveillance study, characterized the burden of enteric fever, including illness severity, in selected settings in Bangladesh, Nepal, and Pakistan. We assessed disease severity, including hospitalization, clinical complications, and death among SEAP participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed clinical and laboratory data from blood culture\u2013confirmed enteric fever cases enrolled in SEAP hospitals and associated network laboratories from September 2016 to September 2019. We used hospitalization and duration of hospital stay as proxies for severity. We conducted a follow-up interview 6 weeks after enrollment to ascertain final outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 8705 blood culture-confirmed enteric fever cases enrolled, we identified 6 deaths (case-fatality ratio, .07%; 95% CI, .01\u2013.13%), 2 from Nepal, 4 from Pakistan, and none from Bangladesh. Overall, 1.7% (90\/5205) of patients recruited from SEAP hospitals experienced a clinical complication (Bangladesh, 0.6% [18\/3032]; Nepal, 2.3% [12\/531]; Pakistan, 3.7% [60\/1642]). The most identified complications were hepatitis (n = 36), septic shock (n = 22), and pulmonary complications\/pneumonia (n = 13). Across countries, 32% (2804\/8669) of patients with hospitalization data available were hospitalized (Bangladesh, 27% [1295\/4868]; Nepal, 29% [455\/1595]; Pakistan, 48% [1054\/2206]), with a median hospital stay of 5 days (IQR, 3\u20137).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>While defined clinical complications and deaths were uncommon at the SEAP sites, the high proportion of hospitalizations and prolonged hospital stays highlight illness severity and the need for enteric fever control measures, including the use of typhoid conjugate vaccines.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa1320","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T23:21:38Z","timestamp":1599088898000},"page":"S222-S231","source":"Crossref","is-referenced-by-count":26,"title":["Illness Severity and Outcomes Among Enteric Fever Cases From Bangladesh, Nepal, and Pakistan: Data From the Surveillance for Enteric Fever in Asia Project, 2016\u20132019"],"prefix":"10.1093","volume":"71","author":[{"given":"Ashley T","family":"Longley","sequence":"first","affiliation":[{"name":"National Foundation for the Centers for Disease Control and Prevention, Atlanta, Georgia, USA"},{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Hemlock","sequence":"additional","affiliation":[{"name":"Applied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashmira","family":"Date","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P","family":"Luby","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R","family":"Andrews","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir K","family":"Saha","sequence":"additional","affiliation":[{"name":"Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh"},{"name":"Bangladesh Institute of Child Health, Dhaka Shishu Hospital, Sher-E-Bangla Nagar, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac I","family":"Bogoch","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad T","family":"Yousafzai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise O","family":"Garrett","sequence":"additional","affiliation":[{"name":"Applied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah N","family":"Qamar","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"2020120106171906200_CIT0001","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2020120106171906200_CIT0002","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020120106171906200_CIT0003","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1473-3099(12)70028-2","article-title":"Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review","volume":"12","author":"Deen","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2020120106171906200_CIT0004","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"2020120106171906200_CIT0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CMR.00002-15","article-title":"Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive salmonella infections","volume":"28","author":"Crump","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2020120106171906200_CIT0006","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0950268807009338","article-title":"Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984\u20132005","volume":"136","author":"Crump","year":"2008","journal-title":"Epidemiol Infect"},{"key":"2020120106171906200_CIT0007","doi-asserted-by":"crossref","first-page":"C16","DOI":"10.1016\/j.vaccine.2015.03.103","article-title":"Challenges in measuring complications and death due to invasive Salmonella infections","volume":"33(Suppl 3)","author":"Qamar","year":"2015","journal-title":"Vaccine"},{"key":"2020120106171906200_CIT0008","doi-asserted-by":"crossref","first-page":"020407","DOI":"10.7189\/jogh.05.020407","article-title":"Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever","volume":"5","author":"Azmatullah","year":"2015","journal-title":"J Glob Health"},{"key":"2020120106171906200_CIT0009","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/cid\/ciy190","article-title":"Case fatality rate of enteric fever in endemic countries: a systematic review and meta-analysis","volume":"67","author":"Pieters","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020120106171906200_CIT0010","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"2020120106171906200_CIT0011","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3855\/jidc.1405","article-title":"Multidrug-resistant typhoid fever: a review","volume":"5","author":"Zaki","year":"2011","journal-title":"J Infect Dev Ctries"},{"key":"2020120106171906200_CIT0012","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant salmonella enterica Serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"MBio"},{"key":"2020120106171906200_CIT0013","article-title":"Introducing typhoid conjugate vaccine in South Asia: lessons learned from the surveillance for enteric fever in Asia project. Clin Infect Dis","author":"Carter"},{"key":"2020120106171906200_CIT0014","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/infdis\/jiy522","article-title":"Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): an overview and lessons learned","volume":"218","author":"Barkume","year":"2018","journal-title":"J Infect Dis"},{"key":"2020120106171906200_CIT0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4269\/ajtmh.17-0586","article-title":"Rotavirus vaccine will improve child survival by more than just preventing diarrhea: evidence from Bangladesh","volume":"98","author":"Saha","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020120106171906200_CIT0016","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1016\/j.vaccine.2015.02.054","article-title":"Towards sustainable public health surveillance for enteric fever","volume":"33","author":"Luby","year":"2015","journal-title":"Vaccine"},{"key":"2020120106171906200_CIT0017","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006454-200105000-00010","article-title":"Typhoid fever in Bangladesh: implications for vaccination policy","volume":"20","author":"Saha","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"2020120106171906200_CIT0018","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1001\/jama.291.21.2607","article-title":"Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia","volume":"291","author":"Vollaard","year":"2004","journal-title":"JAMA"},{"key":"2020120106171906200_CIT0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/infdis\/jiy191","article-title":"Designing comprehensive public health surveillance for enteric fever in endemic countries: importance of including different healthcare facilities","volume":"218","author":"Saha","year":"2018","journal-title":"J Infect Dis"},{"key":"2020120106171906200_CIT0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/infdis\/jiy543","article-title":"Case-fatality ratio of blood culture-confirmed typhoid fever in Dhaka, Bangladesh","volume":"218","author":"Yu","year":"2018","journal-title":"J Infect Dis"},{"key":"2020120106171906200_CIT0021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/cid\/ciy1124","article-title":"Epidemiology of typhoid and paratyphoid: implications for vaccine policy","volume":"68","author":"Saha","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020120106171906200_CIT0022","article-title":"Antimicrobial resistance in typhoidal Salmonella from 3 Asian countries: surveillance of enteric fever in Asia (2016\u20132019).","author":"Qamar","journal-title":"Clin Infect Dis"},{"key":"2020120106171906200_CIT0023","doi-asserted-by":"crossref","first-page":"e0006408","DOI":"10.1371\/journal.pntd.0006408","article-title":"Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: antimicrobial resistance and implications for vaccine policy","volume":"12","author":"Britto","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2020120106171906200_CIT0024","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2334-14-73","article-title":"Risk factors for the development of severe typhoid fever in Vietnam","volume":"14","author":"Parry","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020120106171906200_CIT0025","article-title":"Utilization of blood culture in South Asia for the diagnosis and treatment of febrile illness.","author":"Hemlock","journal-title":"Clin Infect Dis"},{"key":"2020120106171906200_CIT0026","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(18)30350-5","article-title":"Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance","volume":"19","author":"Andrews","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020120106171906200_CIT0027","article-title":"Antibiotic use prior to hospital presentation among individuals with suspected enteric fever in Nepal, Bangladesh, and Pakistan","author":"Vaidya","journal-title":"Clin Infect Dis"},{"key":"2020120106171906200_CIT0028","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.75.3.214","article-title":"Impact of age and drug resistance on mortality in typhoid fever","volume":"75","author":"Bhutta","year":"1996","journal-title":"Arch Dis Child"},{"key":"2020120106171906200_CIT0029","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/clinids\/13.5.832","article-title":"Multidrug-resistant typhoid in children: presentation and clinical features","volume":"13","author":"Bhutta","year":"1991","journal-title":"Rev Infect Dis"},{"key":"2020120106171906200_CIT0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2334-5-37","article-title":"Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi","volume":"5","author":"Kadhiravan","year":"2005","journal-title":"BMC Infect Dis"},{"key":"2020120106171906200_CIT0031","article-title":"Healthcare utilization patterns for acute febrile illness in Bangladesh, Nepal, and Pakistan: Surveillance for Enteric Fever in Asia Project","author":"Andrews","journal-title":"Clin Infect Dis"},{"key":"2020120106171906200_CIT0032","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/infdis\/jiy471","article-title":"The relationship between blood sample volume and diagnostic sensitivity of blood culture for typhoid and paratyphoid fever: a systematic review and meta-analysis","volume":"218","author":"Antillon","year":"2018","journal-title":"J Infect Dis"},{"key":"2020120106171906200_CIT0033","article-title":"Healthcare utilization patterns for acute febrile illness in Bangladesh, Nepal and Pakistan: Surveillance for Enteric Fever in Asia Project","author":"Qazi","journal-title":"Clin Infect Dis"},{"key":"2020120106171906200_CIT0034","volume-title":"Summary of the October 2017 meeting of the Strategic Advisory Group of Experts in Immunization"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_3\/S222\/34608070\/ciaa1320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_3\/S222\/34608070\/ciaa1320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T06:44:35Z","timestamp":1606805075000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/Supplement_3\/S222\/6013556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":34,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2020,12,1]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1320","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,1]]},"published":{"date-parts":[[2020,11,1]]}}}